RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Feb 14, 2014

Total Value: $858M (100.0% shares, 0.0% debt)

Holdings (31)

ACAD ACADIA PHARMACEUTICALS INC 15.3%
Value $131M Shares 5,250,000 Share Price $24.99 * Est. Cost/Share $13.77 Unrealized @ Report Date +71.3%
— ACHILLION PHARMACEUTICALS IN 9.0%
Value $77.55M Shares 23,366,007 Share Price $3.32 Est. Cost/Share $4.78 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 8.5%
Value $72.61M Shares 5,227,272 Share Price $13.89 * Est. Cost/Share $9.24 Unrealized @ Report Date +24.6%
— THERAPEUTICSMD INC 7.1%
Value $60.75M Shares 11,660,108 Share Price $5.21 Est. Cost/Share $3.00 Unrealized @ Report Date —
— NOVAVAX INC 6.4%
Value $55.36M Shares 10,811,888 Share Price $5.12 Est. Cost/Share $2.24 Unrealized @ Report Date —
— OPHTHOTECH CORP 6.0%
Value $51.77M Shares 1,600,455 Share Price $32.35 Est. Cost/Share $32.35 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 5.1%
Value $43.52M Shares 1,641,167 Share Price $26.52 * Est. Cost/Share $15.16 Unrealized @ Report Date +65.5%
SGMO SANGAMO BIOSCIENCES INC 4.9%
Value $41.67M Shares 3,000,000 Share Price $13.89 * Est. Cost/Share $9.24 Unrealized @ Report Date +24.6%
— DYNAVAX TECHNOLOGIES CORP 4.1%
Value $35.05M Shares 17,883,954 Share Price $1.96 Est. Cost/Share $1.67 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 3.8%
Value $33.04M Shares 4,347,456 Share Price $7.60 * Est. Cost/Share $5.07 Unrealized @ Report Date +24.8%
ACAD ACADIA PHARMACEUTICALS INC 3.4%
Value $29.24M Shares 1,169,898 Share Price $24.99 * Est. Cost/Share $13.77 Unrealized @ Report Date +71.3%
XNCR XENCOR INC 2.9%
Value $24.91M Shares 2,725,000 Share Price $9.14 * Est. Cost/Share $8.58 Unrealized @ Report Date 0.0%
— SUNESIS PHARMACEUTICALS INC 2.7%
Value $23.08M Shares 4,869,261 Share Price $4.74 Est. Cost/Share $5.18 Unrealized @ Report Date —
— ARROWHEAD RESH CORP 2.6%
Value $22.23M Shares 2,049,220 Share Price $10.85 Est. Cost/Share $7.05 Unrealized @ Report Date —
— DERMA SCIENCES INC 2.5%
Value $21.59M Shares 1,994,876 Share Price $10.82 Est. Cost/Share $13.35 Unrealized @ Report Date —
— TESARO INC 2.3%
Value $19.77M Shares 700,000 Share Price $28.24 Est. Cost/Share $28.24 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 1.5%
Value $12.77M Shares 752,438 Share Price $16.97 * Est. Cost/Share $17.50 Unrealized @ Report Date +0.4%
— DYAX CORP 1.4%
Value $12.2M Shares 1,619,697 Share Price $7.53 Est. Cost/Share $3.46 Unrealized @ Report Date —
— NEWLINK GENETICS CORP 1.3%
Value $11.01M Shares 500,000 Share Price $22.01 Est. Cost/Share $19.72 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 1.3%
Value $10.92M Shares 656,767 Share Price $16.63 Est. Cost/Share $15.39 Unrealized @ Report Date —
— ROCKWELL MED INC 1.2%
Value $10.44M Shares 1,000,000 Share Price $10.44 Est. Cost/Share — Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 1.2%
Value $9.957M Shares 3,000,000 Share Price $3.32 Est. Cost/Share $4.78 Unrealized @ Report Date —
— BLUEBIRD BIO INC 1.1%
Value $9.806M Shares 467,418 Share Price $20.98 Est. Cost/Share $26.96 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 1.0%
Value $8.595M Shares 661,696 Share Price $12.99 Est. Cost/Share $11.51 Unrealized @ Report Date —
— ENZO BIOCHEM INC 0.8%
Value $6.624M Shares 2,268,653 Share Price $2.92 Est. Cost/Share $2.08 Unrealized @ Report Date —
MGNX MACROGENICS INC 0.6%
Value $5.469M Shares 199,398 Share Price $27.43 * Est. Cost/Share $26.16 Unrealized @ Report Date 0.0%
— PSIVIDA CORP 0.5%
Value $4.715M Shares 1,187,608 Share Price $3.97 Est. Cost/Share $3.97 Unrealized @ Report Date —
— DYAX CORP 0.4%
Value $3.768M Shares 500,000 Share Price $7.54 Est. Cost/Share $3.46 Unrealized @ Report Date —
— MEI PHARMA INC 0.4%
Value $3.271M Shares 408,333 Share Price $8.01 Est. Cost/Share $8.01 Unrealized @ Report Date —
— CHELSEA THERAPEUTICS INTL LT 0.3%
Value $2.957M Shares 666,667 Share Price $4.44 Est. Cost/Share $4.44 Unrealized @ Report Date —
— CORONADO BIOSCIENCES INC 0.3%
Value $2.63M Shares 1,000,000 Share Price $2.63 Est. Cost/Share — Unrealized @ Report Date —